MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-21-2026
Aptorum Group Limited DIO Ratio 2011-2026 | APM
Annual DIO Ratio Aptorum Group Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.89 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.89 | 4.89 | 4.89 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axsome Therapeutics
AXSM
|
168 | $ 156.92 | -1.23 % | $ 7.81 B |  USA |
 |
Kamada Ltd.
KMDA
|
166 | $ 8.5 | -1.39 % | $ 260 M |  Israel |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
BioMarin Pharmaceutical
BMRN
|
644 | $ 54.13 | -1.64 % | $ 10.4 B | USA |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.52 | -5.59 % | $ 178 M | USA |
 |
Cellectis S.A.
CLLS
|
23.3 | $ 3.34 | -4.02 % | $ 116 M |  France |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |